← Leaderboards
Jamie Duane Kapplinger
Mayo Clinic Rochester
$93,066
Attributed
$93,066
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.6K · FY2015–16$50K$37.5K$25K$12.5K$0
'15
'16
Funding mix
By agency
NIH$93,066 · 1
By mechanism
F30$93,066 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Scott H Kaufmann$29,002,745
- Michael John Ackerman$9,249,616
- Harry Long$826,737
- Douglas L Packer$4,389,614
- Cynthia H McCollough$18,009,183
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAccountingAttenuatedAttenuationAllelesBaseBiological ModelsCardiacCardiac MyocytesCardiomyopathiesAutopsyCharacteristicsChildClinical ApplicationClinical ManagementDefectDesignDisease ModelDisease PhenotypeDominant-Negative MutationEventFamilyCessation Of LifeGenerations
Grant awards (2)
Allele-specific RNA Interference Targeting Synonymous Polymorphisms in KCNQ1 as a Novel Therapeutic for Long QT Syndrome$48,576
F30 · FY2016 · HL · contact PI
Allele-specific RNA Interference Targeting Synonymous Polymorphisms in KCNQ1 as a Novel Therapeutic for Long QT Syndrome$44,490
F30 · FY2015 · HL · contact PI